Close

Immunic, Inc. Announces First Psoriasis Patient Enrolled in Ongoing Phase 1 Trial of IMU-935

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/20/2024

1. NFLX
2. TSM
3. ISRG
4. TSLA
5. SPY
6. INFY
7. SNV
8. SMCI
9. SLB
10. PPG


Go back to Immunic, Inc. Announces First Psoriasis Patient Enrolled in Ongoing Phase 1 Trial of IMU-935
(NASDAQ: IMUX) Delayed: 1.18 -0.09 (7.09%)
Previous Close $1.27    52 Week High $ 
Open $1.25    52 Week Low $ 
Day High $1.32    P/E N/A 
Day Low $1.18    EPS $ 
Volume 367,198